• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Financial Services·MCI
Share

Barings Corporate Investors Stocks

$ 16.41Last Updated 03.08.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

$ 337.83M

$ 16.41
Key Takeaways

Risk factor

Modest price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

The Babson Capital Corporate Investors trust, which was previously identified simply as Babson Capital Corporate Investors, operates as a closed-end mutual fund focused on fixed-income investments. This entity, launched and managed by Barings LLC, primarily allocates capital within the United States' fixed-income markets. Its investment strategy targets securities from companies spanning various diversified sectors. A significant portion of its portfolio is dedicated to privately placed, long-term corporate debt obligations that are rated below investment grade. Additionally, the fund invests in marketable debt instruments, including those with investment-grade ratings, other publicly traded debt, and common stocks. Formed in 1971, the trust maintains its legal domicile in the United States.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, overvalued on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 15:10

European stocks are heading toward their widest gap from U.S. stocks since March

16.10.2026 15:00

IPO City: A biotech company developing "switches" to turn off harmful genes has gone public

16.10.2026 13:40

Netflix Replaced Its Chief Content Officer After Its Stock Price Fell 40% Over the Past Year

16.10.2026 12:40

CoreWeave's founders protected their fortunes by selling $3.3 billion worth of shares

16.10.2026 11:41

Tesla has unveiled its "flying" Roadster hypercar. How will this change things for the company?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026